Stoke Therapeutics Ownership | Who Owns Stoke Therapeutics?

Overview Forecast RevenueFinancials Chart

Stoke Therapeutics Ownership Summary

Stoke Therapeutics is owned by 109.54% institutional investors, 4.64% insiders. Skorpios trust is the largest institutional shareholder, holding 12.26% of STOK shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.97% of its assets in Stoke Therapeutics shares.

STOK Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Stoke Therapeutics	109.54%	4.64%	-14.17%
Sector	Healthcare Stocks	279.19%	10.62%	-189.81%
Industry	Biotech Stocks	63.96%	10.74%	25.30%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Skorpios trust	6.91M	12.26%	$76.18M
Blackrock	5.41M	11.70%	$73.08M
Blackrock funding, inc. /de	5.89M	10.45%	$64.94M
Lynx1 capital management lp	5.19M	9.21%	$57.21M
Rtw investments, lp	4.22M	9.14%	$57.08M
Baker bros. advisors lp	4.63M	8.22%	$51.11M
Redmile group	4.59M	8.15%	$50.67M
Morgan stanley	3.48M	7.52%	$47.00M
Cowen and company	3.37M	7.28%	$45.47M
Toronto dominion bank	3.17M	5.63%	$35.00M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Skorpios trust	6.91M	99.80%	$76.18M
Lynx1 capital management lp	5.19M	21.45%	$57.21M
Redmile group	4.59M	3.53%	$50.67M
Birchview capital, lp	210.00K	1.89%	$2.32M
Checkpoint capital	305.39K	1.71%	$3.37M
Cowen and company	3.37M	1.25%	$45.47M
Bioimpact capital	685.83K	1.07%	$7.56M
Siren	2.00M	0.97%	$22.06M
Rtw investments, lp	4.22M	0.88%	$57.08M
Baker bros. advisors lp	4.63M	0.55%	$51.11M

Top Buyers

Holder	Shares	% Assets	Change
Toronto dominion bank	3.17M	0.06%	3.17M
Siren	2.00M	0.97%	2.00M
Blackrock	5.41M	0.00%	1.55M
State street	1.59M	0.00%	1.01M
Blackrock funding, inc. /de	5.89M	0.00%	317.36K

Top Sellers

Holder	Shares	% Assets	Change
Skorpios trust	6.91M	99.80%	-2.00M
Healthcare of ontario pension plan trust fund	-	-	-1.39M
Logos global management lp	-	-	-1.05M
Marshall wace, llp	951.43K	0.01%	-719.30K
Morgan stanley	3.48M	0.00%	-546.21K

New Positions

Holder	Shares	% Assets	Change	Value
Toronto dominion bank	3.17M	0.06%	3.17M	$35.00M
Siren	2.00M	0.97%	2.00M	$22.06M
Norges bank	314.80K	0.00%	314.80K	$3.47M
Tang capital management	300.00K	0.22%	300.00K	$3.31M
Schonfeld strategic advisors	291.80K	0.02%	291.80K	$3.22M

Sold Out

Holder	Change
Quest partners	-2.00
Eversource wealth advisors	-3.00
Nelson, van denburg & campbell wealth management group	-5.00
Ifp advisors	-6.00
Lindbrook capital	-30.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	128	-2.29%	63,381,918	9.17%	109	1.03%	70	4.48%	28	-33.33%
Dec 31, 2024	38	-68.33%	19,005,198	-67.36%	33	0.32%	20	-67.21%	10	-72.22%
Sep 30, 2024	120	3.45%	58,218,197	-5.03%	103	0.59%	61	-25.61%	36	63.64%
Jun 30, 2024	116	5.45%	61,304,739	13.13%	132	0.97%	82	17.14%	22	-15.38%
Mar 31, 2024	110	32.53%	54,189,692	20.45%	117	1.17%	70	112.12%	26	-18.75%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.61M	2.97%	-
Vanguard Total Stock Mkt Idx Inv	1.57M	2.88%	-
BlackRock Health Sciences Opps Inv A	925.94K	1.70%	-
iShares Russell 2000 ETF	918.80K	1.68%	450.00
BGF World Healthscience A2	851.11K	1.56%	-
BGF World Healthscience A2 USD	851.11K	1.56%	-
SPDR® S&P Biotech ETF	696.25K	1.28%	900.00
Vanguard Institutional Extnd Mkt Idx Tr	614.08K	1.12%	1.48K
Fidelity Select Health Care	556.66K	1.02%	556.66K
BlackRock Health Sciences Term Trust	530.09K	0.97%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 04, 2025	Skorpios Trust	-	Sell	$30.60M
Jun 02, 2025	Ticho Barry	CHIEF MEDICAL OFFICER	Sell	$17.45K
Jun 03, 2025	Ticho Barry	CHIEF MEDICAL OFFICER	Sell	$64.89K
May 01, 2025	Ticho Barry	CHIEF MEDICAL OFFICER	Sell	$38.41K
May 02, 2025	Ticho Barry	CHIEF MEDICAL OFFICER	Sell	$228.54K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	5
2025 Q1	-	6
2024 Q4	-	11
2024 Q3	-	7
2024 Q2	-	11

STOK Ownership FAQ

Who Owns Stoke Therapeutics?

Stoke Therapeutics shareholders are primarily institutional investors at 109.54%, followed by 4.64% insiders and -14.18% retail investors. The average institutional ownership in Stoke Therapeutics's industry, Biotech Stocks , is 63.96%, which Stoke Therapeutics exceeds.

Who owns the most shares of Stoke Therapeutics?

Stoke Therapeutics’s largest shareholders are Skorpios trust (6.91M shares, 12.26%), Blackrock (5.41M shares, 11.70%), and Blackrock funding, inc. /de (5.89M shares, 10.45%). Together, they hold 34.40% of Stoke Therapeutics’s total shares outstanding.

Does Blackrock own Stoke Therapeutics?

Yes, BlackRock owns 11.70% of Stoke Therapeutics, totaling 5.41M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 73.08M$. In the last quarter, BlackRock increased its holdings by 1.55M shares, a 40.19% change.

Who is Stoke Therapeutics’s biggest shareholder by percentage of total assets invested?

Skorpios trust is Stoke Therapeutics’s biggest shareholder by percentage of total assets invested, with 99.80% of its assets in 6.91M Stoke Therapeutics shares, valued at 76.18M$.

Who is the top mutual fund holder of Stoke Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Stoke Therapeutics shares, with 2.97% of its total shares outstanding invested in 1.61M Stoke Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools